{"id":"https://openalex.org/W1964513393","doi":"https://doi.org/10.1111/j.2042-7158.1979.tb13416.x","title":"p-Chloroamphetamine-induced hyperthermia pharmacologically distinct from fenfluramine-induced hyperthermia","display_name":"p-Chloroamphetamine-induced hyperthermia pharmacologically distinct from fenfluramine-induced hyperthermia","publication_year":1979,"publication_date":"1979-09-01","ids":{"openalex":"https://openalex.org/W1964513393","doi":"https://doi.org/10.1111/j.2042-7158.1979.tb13416.x","mag":"1964513393","pmid":"https://pubmed.ncbi.nlm.nih.gov/32362"},"language":"en","primary_location":{"id":"doi:10.1111/j.2042-7158.1979.tb13416.x","doi":"https://doi.org/10.1111/j.2042-7158.1979.tb13416.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.2042-7158.1979.tb13416.x","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015469925","display_name":"Raymond Mark Quock","orcid":"https://orcid.org/0000-0001-6616-4778","observed_orcids":["https://orcid.org/0000-0001-6616-4778"]},"institutions":[{"id":"https://openalex.org/I119942576","display_name":"University of the Pacific","ror":"https://ror.org/05ma4gw77","country_code":"US","type":"education","lineage":["https://openalex.org/I119942576"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Raymond M Quock","raw_affiliation_strings":["Department of Pharmacology, School of Medicine, University of Washington , Seattle, Washington 98195,","Department of Physiology-Pharmacology, School of Pharmacy, University of the Pacific, Stockton, California 95211","Department of Pharmacology, School of Medicine, University of Washington, Seattle, Washington 98195,. U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, School of Medicine, University of Washington , Seattle, Washington 98195,","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Department of Physiology-Pharmacology, School of Pharmacy, University of the Pacific, Stockton, California 95211","institution_ids":["https://openalex.org/I119942576"]},{"raw_affiliation_string":"Department of Pharmacology, School of Medicine, University of Washington, Seattle, Washington 98195,. U.S.A","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015111591","display_name":"Barton G. Weick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I119942576","display_name":"University of the Pacific","ror":"https://ror.org/05ma4gw77","country_code":"US","type":"education","lineage":["https://openalex.org/I119942576"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barton G Weick","raw_affiliation_strings":["Department of Pharmacology, School of Medicine, University of Washington , Seattle, Washington 98195,","Department of Physiology-Pharmacology, School of Pharmacy, University of the Pacific, Stockton, California 95211","Department of Pharmacology, School of Medicine, University of Washington, Seattle, Washington 98195,. U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, School of Medicine, University of Washington , Seattle, Washington 98195,","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Department of Physiology-Pharmacology, School of Pharmacy, University of the Pacific, Stockton, California 95211","institution_ids":["https://openalex.org/I119942576"]},{"raw_affiliation_string":"Department of Pharmacology, School of Medicine, University of Washington, Seattle, Washington 98195,. U.S.A","institution_ids":["https://openalex.org/I201448701"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5015469925"],"corresponding_institution_ids":["https://openalex.org/I119942576","https://openalex.org/I201448701"],"apc_list":{"value":2911,"currency":"GBP","value_usd":3839},"apc_paid":null,"fwci":0.6826,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.61177106,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"31","issue":"1","first_page":"27","last_page":"32"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p-chloroamphetamine","display_name":"p-chloroamphetamine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/fenfluramine","display_name":"fenfluramine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hyperthermia","display_name":"hyperthermia","score":0.8389999866485596},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.8980000019073486},{"id":"https://openalex.org/keywords/tryptamine","display_name":"tryptamine","score":0.6769999861717224},{"id":"https://openalex.org/keywords/5-ht-receptor-antagonists","display_name":"5-HT receptor antagonists","score":0.7210000157356262},{"id":"https://openalex.org/keywords/5-ht-uptake-inhibitors","display_name":"5-HT uptake inhibitors","score":0.6610000133514404},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.6840000152587891},{"id":"https://openalex.org/keywords/pheniprazine","display_name":"pheniprazine","score":0.8679999709129333},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9390000104904175},{"id":"https://openalex.org/keywords/cinanserin","display_name":"cinanserin","score":0.8240000009536743},{"id":"https://openalex.org/keywords/cyproheptadine","display_name":"cyproheptadine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/methergoline","display_name":"methergoline","score":0.9110000133514404},{"id":"https://openalex.org/keywords/p-chlorophenylalanine","display_name":"p-chlorophenylalanine","score":0.8690000176429749},{"id":"https://openalex.org/keywords/drug-pretreatment","display_name":"drug pretreatment","score":0.5820000171661377},{"id":"https://openalex.org/keywords/rabbits","display_name":"rabbits","score":0.5680000185966492}],"concepts":[{"id":"https://openalex.org/C2779638493","wikidata":"https://www.wikidata.org/wiki/Q418928","display_name":"Fenfluramine","level":4,"score":0.9797436594963074},{"id":"https://openalex.org/C2777448245","wikidata":"https://www.wikidata.org/wiki/Q7272557","display_name":"Quipazine","level":5,"score":0.8082969784736633},{"id":"https://openalex.org/C2779949491","wikidata":"https://www.wikidata.org/wiki/Q242165","display_name":"Hyperthermia","level":2,"score":0.7447084188461304},{"id":"https://openalex.org/C2778206117","wikidata":"https://www.wikidata.org/wiki/Q417884","display_name":"Cyproheptadine","level":4,"score":0.6313226222991943},{"id":"https://openalex.org/C2776120623","wikidata":"https://www.wikidata.org/wiki/Q6823517","display_name":"Metergoline","level":5,"score":0.574496865272522},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5352206230163574},{"id":"https://openalex.org/C2910298800","wikidata":"https://www.wikidata.org/wiki/Q229944","display_name":"P-Chloroamphetamine","level":5,"score":0.5013048648834229},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.49800872802734375},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.47203245759010315},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4505617022514343},{"id":"https://openalex.org/C24998067","wikidata":"https://www.wikidata.org/wiki/Q4114622","display_name":"Stimulation","level":2,"score":0.44216927886009216},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.43203485012054443},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.39259016513824463},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.32989394664764404},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2798638939857483},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2773175835609436}],"mesh":[{"descriptor_ui":"D000662","descriptor_name":"Amphetamines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001831","descriptor_name":"Body Temperature","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001933","descriptor_name":"Brain Stem","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D003533","descriptor_name":"Cyproheptadine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005277","descriptor_name":"Fenfluramine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006834","descriptor_name":"Hydrazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008238","descriptor_name":"Lysergic Acid Diethylamide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008711","descriptor_name":"Metergoline","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010133","descriptor_name":"p-Chloroamphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010134","descriptor_name":"Fenclonine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.2042-7158.1979.tb13416.x","doi":"https://doi.org/10.1111/j.2042-7158.1979.tb13416.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.2042-7158.1979.tb13416.x","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:32362","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32362","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacy and pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1604447261","https://openalex.org/W1923411089","https://openalex.org/W1969159897","https://openalex.org/W1970590469","https://openalex.org/W1979345820","https://openalex.org/W1989063215","https://openalex.org/W1989702866","https://openalex.org/W1992207161","https://openalex.org/W2018694214","https://openalex.org/W2018966708","https://openalex.org/W2019109615","https://openalex.org/W2027135413","https://openalex.org/W2037512107","https://openalex.org/W2039495717","https://openalex.org/W2040925847","https://openalex.org/W2051573571","https://openalex.org/W2066490926","https://openalex.org/W2067422684","https://openalex.org/W2079355643","https://openalex.org/W2084140032","https://openalex.org/W2089323156","https://openalex.org/W2091016764","https://openalex.org/W2092797300","https://openalex.org/W2093015887","https://openalex.org/W2093239717","https://openalex.org/W2113542789","https://openalex.org/W2141376446","https://openalex.org/W2150430125","https://openalex.org/W2197062325","https://openalex.org/W2253142117","https://openalex.org/W2260661700","https://openalex.org/W2406065035"],"related_works":["https://openalex.org/W2090882709","https://openalex.org/W2089323156","https://openalex.org/W2016264491","https://openalex.org/W2399614578","https://openalex.org/W1969159897","https://openalex.org/W2088902486","https://openalex.org/W1975951951","https://openalex.org/W2013624535","https://openalex.org/W2479934132","https://openalex.org/W4250205026"],"abstract_inverted_index":{"The":[0,44,118],"influence":[1],"of":[2,9,49,91,102,135],"various":[3],"drug":[4,151],"pretreatments":[5],"upon":[6,162],"the":[7,12,55,63,71,77,89,97,133,157,165],"responses":[8,48,98,110,115,159,167],"rabbits":[10,25],"to":[11,99,111,116,145],"putative":[13],"indirect":[14],"5-hydroxytryptaminergic":[15,78],"agonists":[16],"p-chloroamphetamine":[17],"(PCA)":[18],"and":[19,31,41,46,68,127,149],"fenfluramine":[20,37,92,112,166],"were":[21,52,137],"examined.":[22],"In":[23],"naive":[24],"PCA":[26,158],"evoked":[27],"hyperthermia,":[28],"behavioural":[29,42,47,131],"excitation":[30],"prominent":[32],"forepaw":[33,128],"clonic":[34],"activity,":[35],"while":[36,164],"produced":[38],"only":[39,94,138],"hyperthermia":[40,126],"stimulation.":[43],"hyperthermic":[45],"both":[50,124],"agents":[51],"reduced":[53],"by":[54,62,70],"5-hydroxytryptamine":[56],"(5-HT)":[57],"uptake":[58],"inhibitor,":[59,66],"fluoxetine,":[60],"potentiated":[61],"monoamine":[64],"oxidase":[65],"pheniprazine,":[67],"unaltered":[69],"dopaminergic":[72],"antagonist,":[73],"haloperidol.":[74],"Pretreatment":[75],"with":[76,106],"receptor":[79,120],"blockers":[80],"cinanserin,":[81],"cyproheptadine":[82],"or":[83],"D-2-bromolysergic":[84],"acid":[85],"diethylamide":[86],"markedly":[87],"attenuated":[88],"effects":[90,134,152],"but":[93],"slightly":[95],"influenced":[96],"PCA.":[100,117],"Depeletion":[101],"central":[103],"5-HT":[104],"stores":[105],"p-chlorophenylalanine":[107],"also":[108],"affected":[109],"more":[113],"than":[114],"tryptaminergic":[119],"blocker":[121],"methergoline":[122],"abolished":[123],"PCA-induced":[125],"clonus--but":[129],"not":[130],"stimulation--while":[132],"flenfluramine":[136],"partly":[139],"reduced.":[140],"We":[141],"interpret":[142],"these":[143],"data":[144],"mean":[146],"that":[147],"PCA-":[148],"fenfluramine-induced":[150],"have":[153],"different":[154],"underlying":[155],"mechanisms,":[156],"relying":[160],"possibly":[161],"tryptamine":[163],"are":[168],"5-hydroxytryptaminergic.":[169]},"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}